This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

NovaFarma drug bid-rigging cartel probe suspended amid settlement

( September 23, 2016, 12:48 GMT | Official Statement) -- MLex Summary: A drug bid-rigging cartel investigation into NovaFarma, a pharmaceutical company, was suspended because the company settled the probe with Brazilian antitrust officials on Sep. 14, according to a statement published today in Brazil’s Official Journal. NovaFarma agreed to pay 7.78 million reais ($2.42 million). The Administrative Council for Economic Defense is investigating whether pharmaceutical companies colluded to allocate the market for supplying medicine in several Brazilian states, including Minas Gerais, São Paulo, Bahia and Pernambuco. Companies, including Cristália Produtos Químicos Farmacêuticos, Laboratório Teuto Brasileiro and Torrent do Brasil are under scrutiny by CADE officials.OJ statement follows in Portuguese....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections